UNITED STATES DISTRICT COURT
District of Minnesota

IN THE UNITED STATES DISTRICT COURT

KELLYN CLAY,
  Plaintiff,

v.

UNITED STATES OF AMERICA,
by and through its agencies including but not limited to
the Central Intelligence Agency (CIA), Department of Defense (DoD),
and Department of Justice (DOJ),

and

PALANTIR TECHNOLOGIES INC.,
a private defense contractor headquartered in Denver, Colorado,

and

AMAZON.COM, INC.,
a multinational e-commerce corporation headquartered in Seattle, Washington,

and

JOHN DOE CONTRACTING AGENCIES AND AFFILIATES,
whose names and identities are presently unknown,

and

WILLIAM ALTON CLAY,
individually and in his capacity as executor of the Estate of Eugenia Clay Head,
  Defendants.

⸻ 

SUBPOENA TO PRODUCE DOCUMENTS, INFORMATION, OR OBJECTS OR TO PERMIT INSPECTION OF PREMISES
Rule 45, Federal Rules of Civil Procedure

TO:
Minnesota Department of Health (MDH)
Freeman Building
625 Robert St. N.
P.O. Box 64975
St. Paul, MN 55164-0975

⸻ 

YOU ARE COMMANDED to produce at the time, date, and place set forth below the following documents, electronically stored information, or objects, as described in Schedule A.

Production Location: [Your Attorney’s Office / Clerk of Court]
Date and Time: [Insert]

⸻

Schedule A — Requested Materials
	1.	Medical Protocols
All documents, research studies, or internal communications from 2000 to present concerning the administration of vitamin D3, testosterone, or other hormonal or nutritional protocols that acknowledge or predict effects on vocal cords, speech capacity, or related musculature and fascia.
	2.	Speech-Related Adverse Effects
All adverse event reports, case studies, or incident files documenting loss of speech, acute allergic reaction to vocal exertion, or anaphylaxis associated with supplement or pharmaceutical administration.
	3.	Monitoring or Retaliation Programs
All documents referencing monitoring, targeting, or intervening medically in individuals identified for expressive activity (speech, writing, public dissent), including communications with federal contractors or private corporations.
	4.	Suppression of Expression via Medical Intervention
Any communications, directives, or memoranda concerning the use of medical protocols to restrict, impair, or otherwise suppress the ability of individuals to communicate verbally.
	5.	Coordination with Private Entities
All contracts, MOUs, or correspondence between MDH and Palantir Technologies, Amazon, or their affiliates from 2008 to present concerning health surveillance, supplement distribution, or interventions tied to speech, expression, or behavioral monitoring.
